SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/A17D1D85B6477165C57A3F018215D514C00D95DC1C97BC9168DCDB662CC34F931D2E73CE034DE80B668A9EE3A026C540>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/A17D1D85B6477165C57A3F018215D514C00D95DC1C97BC9168DCDB662CC34F931D2E73CE034DE80B668A9EE3A026C540
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/A17D1D85B6477165C57A3F018215D514C00D95DC1C97BC9168DCDB662CC34F931D2E73CE034DE80B668A9EE3A026C540
http://www.w3.org/2000/01/rdf-schema#comment
"Data indicate that the interferon regulatory factor (IRF1) promotion was observed in cancer cell lines treated with different MEK inhibitors or with RNAi oligonucleotides against extracellular signal-regulated kinases (ERK1/2)."
xsd:string
http://purl.uniprot.org/uniprot/#_8AD296F37FF17F4739B8D22FC899E6CB2EF9B074AA55B9A3C51D59969CDFE6472EEA497C5AD78C6BC2FAA65FA5A62C02
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/A17D1D85B6477165C57A3F018215D514C00D95DC1C97BC9168DCDB662CC34F931D2E73CE034DE80B668A9EE3A026C540
http://purl.uniprot.org/uniprot/A0A0B6XK11
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A17D1D85B6477165C57A3F018215D514C00D95DC1C97BC9168DCDB662CC34F931D2E73CE034DE80B668A9EE3A026C540
http://purl.uniprot.org/uniprot/#_A0A0B6XK11-mappedCitation-25497010
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A17D1D85B6477165C57A3F018215D514C00D95DC1C97BC9168DCDB662CC34F931D2E73CE034DE80B668A9EE3A026C540